TAZOCIN 2.25 G.
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
PIPERACILLIN AS SODIUM 2 G/VIAL; TAZOBACTAM SODIUM 0.25 G/VIAL
Available from:
NEOPHARM LTD
ATC code:
J01CR05
Pharmaceutical form:
POWDER FOR SOLUTION FOR INJECTION
Administration route:
I.V
Manufactured by:
WYETH PIPER. DIV.OF WYETH HOLDINGS CORP.
Therapeutic group:
PIPERACILLIN AND ENZYME INHIBITOR
Therapeutic indications:
Antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. Tazocin in combination with an aminoglycoside, is indicated for suspected bacterial infections in neutropenic adults or children above 2 years. Appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.
Authorization date:
2010-06-01
